Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study.
Ismaila, Afisi S
JournalValue in Health Regional Issues
MetadataShow full item record
AbstractObjectives: Despite a growing prevalence of respiratory diseases in recent decades in China, limited evidence is available on the health and economic burden of chronic obstructive pulmonary disease (COPD). We estimated the 20-year health and economic burden of COPD in China from 2020 to 2039. Methods: We created a probabilistic dynamic open-cohort Markov model of COPD for the Chinese population aged ≥40 years. Projections of population growth and urbanization rates were obtained from the United Nations Population Division. Other parameter inputs including smoking prevalence, COPD prevalence and severity distributions, disease-related costs, and utility weights were obtained from the most recent published literature. We modeled number of COPD patients, excess mortality due to COPD, exacerbations, COPD-attributable losses of quality-adjusted life-years, and direct and indirect COPD costs over the 20 years. Results: The number of COPD patients was projected to increase from 88.3 million in 2020 to 103.3 million in 2039. The projected total losses of quality-adjusted life-years and the excess mortality due to COPD were, respectively, estimated to be 253.6 million and 3.9 million over the 20 years. The projected 20-year total discounted direct and indirect costs of COPD were, respectively, $3.1 trillion and $360.5 billion. The projected health and economic burden was higher in males and urban areas. Conclusions: COPD is projected to inflict a substantial burden to the society and the health care system in China. Effective strategies for prevention and early management of COPD are needed to mitigate the forthcoming disease burden.
Rights/TermsCopyright © 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.
Monte Carlo method
chronic obstructive pulmonary disease
global burden of disease
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19604
- Projecting Long-term Health and Economic Burden of COPD in the United States.
- Authors: Zafari Z, Li S, Eakin MN, Bellanger M, Reed RM
- Issue date: 2021 Apr
- Future impact of various interventions on the burden of COPD in Canada: a dynamic population model.
- Authors: Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, Sin D
- Issue date: 2012
- Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China.
- Authors: Cai L, Wang XM, Liu L, Zhao Y, Golden AR
- Issue date: 2023 Jan 20
- Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
- Authors: GBD 2015 Chronic Respiratory Disease Collaborators
- Issue date: 2017 Sep
- [Burden of chronic obstructive pulmonary disease attributable to ambient ozone pollution in 1990 and 2013 in China].
- Authors: Cui J, Yin P, Wang LJ, Liu SW, Li YC, Liu YN, Liu JM, You JL, Zeng XY, Zhou MG
- Issue date: 2016 May